NO20020176L - Sykliske peptidderivater som inhibitorer for intergrin <alfa>v<beta>6 - Google Patents
Sykliske peptidderivater som inhibitorer for intergrin <alfa>v<beta>6Info
- Publication number
- NO20020176L NO20020176L NO20020176A NO20020176A NO20020176L NO 20020176 L NO20020176 L NO 20020176L NO 20020176 A NO20020176 A NO 20020176A NO 20020176 A NO20020176 A NO 20020176A NO 20020176 L NO20020176 L NO 20020176L
- Authority
- NO
- Norway
- Prior art keywords
- phe
- peptide derivatives
- intergrin
- alfa
- inhibitors
- Prior art date
Links
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 102000006495 integrins Human genes 0.000 abstract 1
- 108010044426 integrins Proteins 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen vedrører nye peptidderivater med formel (I): syklo-(Arg-X'-Asp-X2-X3-X4-X5-X6-R1); som er biologisk aktive som Ugander for integrin avp6) X1 er Ser, Gly eller Thr; X2 er Leu, Ile, Nle, Val eller Phe; X3 er Asp, Glu, Lys eller Phe; X4 er Gly, Ala eller Ser; X5 er Leu, Ile, Nle, Val eller Phe; X6 er Arg, Har eller Lys; og R1 er utelatt eller er ett eller flere co-amino- karboksylsyreradikaler, hvor o-aminokarboksyl- syreradikalet eller -radikalene er fra 500 til 2500 pm lange. Aminosyrene kan også være derivatisert og D- og L-formene av de optisk aktive aminosyreradikalene er omfattet. Oppfinnelsen vedrører også de fysiologisk egnede salter og solvater av derivatene ifølge oppfinnelsen.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19933173A DE19933173A1 (de) | 1999-07-15 | 1999-07-15 | Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶ |
| PCT/EP2000/006188 WO2001005810A2 (de) | 1999-07-15 | 2000-07-03 | CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6? |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20020176D0 NO20020176D0 (no) | 2002-01-14 |
| NO20020176L true NO20020176L (no) | 2002-01-14 |
Family
ID=7914891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020176A NO20020176L (no) | 1999-07-15 | 2002-01-14 | Sykliske peptidderivater som inhibitorer for intergrin <alfa>v<beta>6 |
Country Status (23)
| Country | Link |
|---|---|
| EP (2) | EP1196433B1 (no) |
| JP (1) | JP2003505395A (no) |
| KR (1) | KR20020010928A (no) |
| CN (1) | CN1361792A (no) |
| AR (1) | AR024742A1 (no) |
| AT (1) | ATE340803T1 (no) |
| AU (1) | AU772782C (no) |
| BR (1) | BR0012418A (no) |
| CA (1) | CA2379022A1 (no) |
| CZ (1) | CZ200226A3 (no) |
| DE (2) | DE19933173A1 (no) |
| DK (1) | DK1196433T3 (no) |
| ES (1) | ES2273703T3 (no) |
| HK (1) | HK1048641A1 (no) |
| HU (1) | HUP0201925A3 (no) |
| MX (1) | MXPA02000465A (no) |
| NO (1) | NO20020176L (no) |
| PL (1) | PL354363A1 (no) |
| PT (1) | PT1196433E (no) |
| SK (1) | SK262002A3 (no) |
| TW (1) | TWI226890B (no) |
| WO (1) | WO2001005810A2 (no) |
| ZA (1) | ZA200201275B (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2438663C (en) * | 2001-02-19 | 2009-09-15 | Takara Bio Inc. | Cyclic peptide |
| DE10118550A1 (de) * | 2001-04-14 | 2002-10-17 | Merck Patent Gmbh | Liganden des Integrins alpha¶nu¶beta¶6¶ |
| EP1603512A2 (en) | 2003-03-17 | 2005-12-14 | Albany Molecular Research, Inc. | Novel cyclosporins |
| EP1667668B1 (en) * | 2003-10-01 | 2008-07-02 | MERCK PATENT GmbH | Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents |
| ES2436170T3 (es) * | 2003-12-03 | 2013-12-27 | The Scripps Research Institute | Anticuerpos y péptidos específicos de la integrina alfa II beta3 |
| US7378391B2 (en) | 2004-09-29 | 2008-05-27 | Amr Technology, Inc. | Cyclosporin alkyne analogues and their pharmaceutical uses |
| WO2006039164A2 (en) | 2004-09-29 | 2006-04-13 | Amr Technology, Inc. | Novel cyclosporin analogues and their pharmaceutical uses |
| WO2006041631A2 (en) | 2004-10-06 | 2006-04-20 | Amr Technology, Inc. | Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| GB0520068D0 (en) * | 2005-10-03 | 2005-11-09 | Cancer Res Technology | av peptide ligand |
| US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
| US7696166B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| TW200815474A (en) | 2006-08-03 | 2008-04-01 | Astrazeneca Ab | Antibodies alphaVbeta6 and uses thereof |
| EP2784511A1 (en) | 2013-03-27 | 2014-10-01 | Universität Zürich | Integrin alpha-v-beta6 for diagnosis/prognosis of colorectal carcinoma |
| SI3350222T1 (sl) | 2015-09-18 | 2022-01-31 | Technische Universitaet Muenchen | Ligandi za integrin avbeta6, sinteza in uporaba le-teh |
| MA47697A (fr) | 2017-02-28 | 2020-01-08 | Morphic Therapeutic Inc | Inhibiteurs de l'(alpha-v)(bêta-6) intégrine |
| MA52117A (fr) | 2017-02-28 | 2022-04-06 | Morphic Therapeutic Inc | Inhibiteurs de l'intégrine (alpha-v) (bêta-6) |
| US11332498B2 (en) | 2017-03-17 | 2022-05-17 | Technische Universitat Munchen | Ligands for integrin αVβ8, synthesis and uses thereof |
| GB201706472D0 (en) * | 2017-04-24 | 2017-06-07 | Cancer Res Tech Ltd | Tumour-targeting peptide variants |
| WO2020047208A1 (en) | 2018-08-29 | 2020-03-05 | Morphic Therapeutic, Inc. | Inhibitors of (alpha-v)(beta-6) integrin |
| EP4086254B1 (en) | 2018-08-29 | 2024-12-18 | Morphic Therapeutic, Inc. | Integrin inhibitors |
| FI3844162T3 (fi) | 2018-08-29 | 2025-03-27 | Morphic Therapeutic Inc | Alfa v beeta6 -integriinin estäjiä |
| JP7787083B2 (ja) * | 2020-03-12 | 2025-12-16 | テフニーシェ ウニヴェルジテート ミュンヘン | アルファ－ｖ－ベータ－６－インテグリンをインビボでアドレッシングするための環状ペプチド及びそれらのコンジュゲート |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4472305A (en) | 1983-05-17 | 1984-09-18 | Sterling Drug Inc. | Hexapeptide amides |
| DE4310643A1 (de) | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| DE19538741A1 (de) | 1995-10-18 | 1997-04-24 | Merck Patent Gmbh | Cyclopeptidderivate |
| EP1140989A1 (de) * | 1998-12-19 | 2001-10-10 | MERCK PATENT GmbH | Inhibitoren des integrins alpha(v) beta(6) |
-
1999
- 1999-07-15 DE DE19933173A patent/DE19933173A1/de not_active Withdrawn
-
2000
- 2000-07-03 ES ES00943971T patent/ES2273703T3/es not_active Expired - Lifetime
- 2000-07-03 KR KR1020017015995A patent/KR20020010928A/ko not_active Withdrawn
- 2000-07-03 PT PT00943971T patent/PT1196433E/pt unknown
- 2000-07-03 CN CN00810415A patent/CN1361792A/zh active Pending
- 2000-07-03 CA CA002379022A patent/CA2379022A1/en not_active Abandoned
- 2000-07-03 AU AU58236/00A patent/AU772782C/en not_active Ceased
- 2000-07-03 MX MXPA02000465A patent/MXPA02000465A/es unknown
- 2000-07-03 PL PL00354363A patent/PL354363A1/xx unknown
- 2000-07-03 EP EP00943971A patent/EP1196433B1/de not_active Expired - Lifetime
- 2000-07-03 AT AT00943971T patent/ATE340803T1/de not_active IP Right Cessation
- 2000-07-03 JP JP2001511467A patent/JP2003505395A/ja active Pending
- 2000-07-03 HU HU0201925A patent/HUP0201925A3/hu unknown
- 2000-07-03 HK HK03100378.9A patent/HK1048641A1/zh unknown
- 2000-07-03 DK DK00943971T patent/DK1196433T3/da active
- 2000-07-03 SK SK26-2002A patent/SK262002A3/sk unknown
- 2000-07-03 BR BR0012418-4A patent/BR0012418A/pt not_active Application Discontinuation
- 2000-07-03 WO PCT/EP2000/006188 patent/WO2001005810A2/de not_active Ceased
- 2000-07-03 DE DE50013525T patent/DE50013525D1/de not_active Expired - Fee Related
- 2000-07-03 CZ CZ200226A patent/CZ200226A3/cs unknown
- 2000-07-03 EP EP06019918A patent/EP1754714A1/de not_active Withdrawn
- 2000-07-13 TW TW089113997A patent/TWI226890B/zh not_active IP Right Cessation
- 2000-07-14 AR ARP000103621A patent/AR024742A1/es unknown
-
2002
- 2002-01-14 NO NO20020176A patent/NO20020176L/no unknown
- 2002-02-14 ZA ZA200201275A patent/ZA200201275B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR024742A1 (es) | 2002-10-23 |
| NO20020176D0 (no) | 2002-01-14 |
| WO2001005810A2 (de) | 2001-01-25 |
| CA2379022A1 (en) | 2001-01-25 |
| EP1754714A1 (de) | 2007-02-21 |
| PT1196433E (pt) | 2007-01-31 |
| PL354363A1 (en) | 2004-01-12 |
| AU5823600A (en) | 2001-02-05 |
| AU772782B2 (en) | 2004-05-06 |
| CZ200226A3 (cs) | 2002-04-17 |
| AU772782C (en) | 2005-01-27 |
| EP1196433B1 (de) | 2006-09-27 |
| DE50013525D1 (de) | 2006-11-09 |
| BR0012418A (pt) | 2002-03-26 |
| DK1196433T3 (da) | 2007-02-12 |
| DE19933173A1 (de) | 2001-01-18 |
| HUP0201925A3 (en) | 2002-11-28 |
| WO2001005810A3 (de) | 2001-05-17 |
| HK1048641A1 (zh) | 2003-04-11 |
| HUP0201925A2 (en) | 2002-10-28 |
| TWI226890B (en) | 2005-01-21 |
| SK262002A3 (en) | 2002-07-02 |
| KR20020010928A (ko) | 2002-02-06 |
| CN1361792A (zh) | 2002-07-31 |
| ZA200201275B (en) | 2003-08-22 |
| MXPA02000465A (es) | 2002-07-30 |
| EP1196433A2 (de) | 2002-04-17 |
| JP2003505395A (ja) | 2003-02-12 |
| ATE340803T1 (de) | 2006-10-15 |
| ES2273703T3 (es) | 2007-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20020176L (no) | Sykliske peptidderivater som inhibitorer for intergrin <alfa>v<beta>6 | |
| AU2007258387B2 (en) | Peptide fragments for inducing synthesis of extracellular matrix proteins | |
| CA1341336C (en) | Neuropeptide y agonists | |
| DE60031999D1 (de) | Stabilisierte flüssige pharmazeutische zusammensetzung enthaltend polypeptide | |
| IT1196500B (it) | Derivati dell'acido malonico e metodi per la loro sintesi | |
| SE448461B (sv) | Nya peptidyl-argininaldehydderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem | |
| IE51259B1 (en) | Angiotensin converting enzyme inhibitors | |
| AR006517A1 (es) | Polipeptido que alcanza un total de alrededor de 30 aminoacidos; sustancia, peptidomimetico y composicion farmaceutica resultantes; usos del polipeptidoy proceso para la sintesis del polipeptido. | |
| IT1227907B (it) | Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento | |
| DK0479912T3 (da) | Fremgangsmåde til hæmning af N-endereglens forløb i levende celler | |
| Robl et al. | Dual metalloprotease inhibitors. I. Constrained peptidomimetics of mercaptoacyl dipeptides | |
| JP6548126B2 (ja) | Ｉｉｉ型コラーゲン産生促進剤 | |
| DE602004029173D1 (de) | Il-21-derivate | |
| NO955067L (no) | FVII/TF peptider | |
| ATE248806T1 (de) | N-3, 3-dimethylbutyl-l-asparaginsäure und ihre ester, verfahren zur herstellung dieser und das verfahren um daraus n-(n-(3,3-dimethylbutyl)-l- alpha-aspartyl)-l-phenylalanin-1-methylester herzustellen | |
| ATE245168T1 (de) | Peptide, die anti-zellanhaftungsaktivität aufweisen | |
| US5395823A (en) | Neuropeptide Y agonists and partial agonists | |
| NO20016341L (no) | Inhibitorer for integrinet <alfa>v<beta>6 | |
| WO1998040091A1 (en) | Microbicidal peptides and methods of use | |
| Sugano et al. | Studies of peptide antibiotics. XXX. Syntheses of gramicidin S analogs containing N-methylleucine in place of leucine | |
| CA2146367C (en) | Calcium channel blocking polypeptides from heteropoda venatoria | |
| WO2002083729A3 (en) | Polypeptides derived from amyloid precursor peptide (app) and their uses | |
| WO2009152085A1 (en) | Novel bmp-12-related proteins and methods of their manufacture | |
| DE60324936D1 (de) | Bicyclische oligopeptide und deren verwendung als glucagon rezeptorantagonist | |
| Goolcharran | Deamidation and diketopiperazine formation in model peptides and recombinant human vascular endothelial growth factor |